GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Epigenomics ECX.F · EUR

Health Care · Frankfurt · 🇩🇪 Germany

Compare

0.87

0.00%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Epigenomics — daily FWB:ECX

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Epigenomics on TradingView ↗
Market value
€765,600
Last close × shares
Volume
108
Shares, 9 Nov 2026

About Epigenomics

Its shares trade on Frankfurt under the ticker ECX.F. It has been listed since 19 July 2004. In the fiscal year to 31 December 2023, it reported revenue of €339,200 and a net loss of €4.5m. At that date it held total assets of €12.8m.

Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. The company is headquartered in Berlin, Berlin. The company went IPO on 2004-07-19. The company develops and commercializes blood-based diagnostic products across multiple cancer indications. The firm's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. The company also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The firm is present in Europe and the United States.

Figures and description from our data supplier, not checked against the company's own report.

More about Epigenomics →

Latest on Epigenomics

Our reporting

We have not reported on Epigenomics yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Epigenomics's ticker?

Epigenomics trades as ECX.F on Frankfurt, under ISIN DE000A37FT41.

What was Epigenomics's last closing price?

0.87 on 9 Nov 2026. The figure is in EUR and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.